Capricor Therapeutics, Inc.
CAPR
$6.40
-$0.2001-3.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -150.39% | -126.48% | -81.57% | -16.64% | 4.38% |
| Total Depreciation and Amortization | 28.00% | 28.12% | 33.33% | 42.42% | 56.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 55.34% | 47.47% | 33.31% | 38.70% | 47.40% |
| Change in Net Operating Assets | 108.72% | 75.30% | 8.23% | -2,029.43% | -458.44% |
| Cash from Operations | -56.12% | -45.33% | -56.25% | -76.01% | -90.76% |
| Capital Expenditure | -60.65% | 10.79% | 24.84% | 39.65% | 29.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -968.67% | -7,602.89% | -1,702.15% | -84.62% | 26.78% |
| Cash from Investing | -1,276.13% | -6,903.74% | -2,374.46% | -91.71% | 67.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 435.17% | 440.19% | 497.23% | 1,668.75% | 295.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 435.17% | 440.19% | 497.23% | 1,668.75% | 295.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,374.72% | 614.24% | -166.93% | 10,301.52% | 112.98% |